CORD-19:02d18b4f484a0420c21595a95b8765125d4a484c / 14060-14322 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T81","span":{"begin":0,"end":262},"obj":"Sentence"}],"text":"Consistent with the biological result, structural analyses demonstrated that SARS Spike protein contacts the tip of subdomain I of the ACE2 catalytic domain but does not affect the subdomain II nor occludes the peptidase active site ( Fig. 2) (Li et al., 2005) ."}

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T81","span":{"begin":0,"end":262},"obj":"Sentence"},{"id":"TextSentencer_T81","span":{"begin":0,"end":262},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Consistent with the biological result, structural analyses demonstrated that SARS Spike protein contacts the tip of subdomain I of the ACE2 catalytic domain but does not affect the subdomain II nor occludes the peptidase active site ( Fig. 2) (Li et al., 2005) ."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T40","span":{"begin":77,"end":81},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Consistent with the biological result, structural analyses demonstrated that SARS Spike protein contacts the tip of subdomain I of the ACE2 catalytic domain but does not affect the subdomain II nor occludes the peptidase active site ( Fig. 2) (Li et al., 2005) ."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T42","span":{"begin":109,"end":112},"obj":"Body_part"}],"attributes":[{"id":"A42","pred":"uberon_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/UBERON_2001840"}],"text":"Consistent with the biological result, structural analyses demonstrated that SARS Spike protein contacts the tip of subdomain I of the ACE2 catalytic domain but does not affect the subdomain II nor occludes the peptidase active site ( Fig. 2) (Li et al., 2005) ."}